Related Experiment Videos
[Repeat liver resection in colorectal liver metastases]
W Meyer1, H Bödeker, K H Schultheis
1Abteilung für Abdominal, Thorax- und Endokrine Chirugie, Klinikum Nürnberg Nord.
Summary
Repeated liver resections offer a chance for prolonged survival in patients with colorectal cancer metastases. This study shows low complication rates and potential for long-term disease-free survival after these procedures.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Colorectal Cancer Management
Context:
- Colorectal cancer frequently metastasizes to the liver, posing a significant challenge for long-term patient survival.
- Operative resection remains the only curative option for liver metastases, with repeated resections gaining attention due to limited alternatives.
- The study focuses on recurrent, operable liver metastases from colorectal cancer, evaluating the efficacy of repeat surgical interventions.
Purpose:
- To evaluate the outcomes of repeated liver resections in patients with recurrent colorectal cancer metastases.
- To assess the safety and efficacy of repeat hepatectomies in terms of complication rates and survival.
- To compare the survival benefit of operative resection versus non-operative management for liver metastases.
Summary:
- Twelve recurrent liver resections were performed on 8 patients with colorectal cancer metastases between 1986 and 1994.
- Procedures included anatomic hemihepatectomy, segmentectomy, or bisegmentectomy, with a mean interval of 14 months between resections.
- Postoperative complication rate was 16% with no in-hospital mortality; 5 patients are alive with a mean follow-up of 14 months, 3 of whom are tumor-free.
Impact:
- Repeated liver resections can achieve prolonged survival times for select patients with colorectal liver metastases.
- This approach offers a potential for long-term disease control and improved quality of life.
- The findings support considering operative risk and patient selection for repeat liver resections in managing metastatic colorectal cancer.